Orrick advised Catalyst Biosciences, Inc. on the deal. South San Francisco-based biopharmaceutical company Catalyst Biosciences, Inc. announced its acquisition of the F351 program, a next-generation fibrosis drug,...
You must be a Standard 1 Year member to access this content.
Orrick advised Medical Microinstruments on the deal, while McDermott Will & Emery assisted the investors. Medical Microinstruments, Inc. (MMI), a robotics company dedicated to improving clinical...
You must be a Standard 1 Year member to access this content.
Orrick advised Aledade on the deal. Aledade announced its $123 million Series E financing round. Returning investor OMERS Growth Equity led the round, which also included Fidelity...
You must be a Standard 1 Year member to access this content.
Orrick advised Catalyst Biosciences, Inc. on the deal. South San Francisco-based biopharmaceutical company Catalyst Biosciences, Inc. (NASDAQ: CBIO) announced the sale of its complement asset portfolio for...
You must be a Standard 1 Year member to access this content.
Orrick Herrington & Sutcliffe advised neuroloop GmbH on the deal, while McDermott Will & Emery advised Merck KGaA. Neuroloop GmbH, part of B. Braun Group, announced a...
You must be a Standard 1 Year member to access this content.
